SCHEMBL12070646

SCHEMBL12070646

O=C(Cl)c1cc(-c2ccccc2)cc(-c2ccccc2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 1/20 0.57
EGFR P00533 1/20 0.52
DHODH Q02127 3/20 0.52
HDAC8 Q9BY41 1/20 0.47
RXRA P19793 1/20 0.46
RXRB P28702 1/20 0.46
MAPT P10636 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
AKR1C2 P52895 1/20 0.44
AKR1C1 Q04828 1/20 0.44
MKNK1 Q9BUB5 1/20 0.43
MKNK2 Q9HBH9 1/20 0.43
ERCC5 P28715 1/20 0.43
FEN1 P39748 1/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
CTDSP1 Q9GZU7 1/20 0.42
ACMSD Q8TDX5 1/20 0.41
PTPN1 P18031 1/20 0.41
ALDH1A1 P00352 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28453166 0.98 KMO (0.55) KMOEGFRDHODHHDAC8RXRA
SCHEMBL9622262 0.95 DHODH (0.55) KMOEGFRDHODHHDAC8RXRA
SCHEMBL27843569 0.91 KMO (0.56) KMODHODHHDAC8RXRARXRB
SCHEMBL22064857 0.89 EGFR (0.60) KMOEGFRDHODHRXRARXRB
SCHEMBL699008 0.84 KMO (0.67) KMODHODHHDAC8RXRARXRB
SCHEMBL30698052 0.84 KMO (0.67) KMODHODHHDAC8RXRARXRB
Biphenyl SCHEMBL505047 0.83 RAB9A (0.52) KMOHDAC8MAPTSMN1; SMN2NPC1
Hydrogen Sulfide SCHEMBL27896825 0.83 KMO (0.64) KMODHODHHDAC8RXRARXRB
SCHEMBL12551713 0.81 KMO (0.61) KMOEGFRDHODHHDAC8MAPT
SCHEMBL15081115 0.81 KMO (0.61) KMOEGFRDHODHHDAC8MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230284527-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-09-07 US disclosed
US-20230284527-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-09-07 US disclosed
EP-4194458-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-06-14 EP disclosed
US-9273080-B2 Metal complexes MEREK PATENT GMBH (DE) 2016-03-01 US disclosed
US-9273080-B2 Metal complexes MEREK PATENT GMBH (DE) 2016-03-01 US disclosed
US-9273080-B2 Metal complexes MEREK PATENT GMBH (DE) 2016-03-01 US disclosed
US-20130082209-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2013-04-04 US disclosed
US-20130082209-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2013-04-04 US disclosed
US-20130082209-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2013-04-04 US disclosed
WO-2011157339-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2011-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130082209-A1 METAL COMPLEXES MCOLN2, MCOLN1, AP1M1 KMO 2983/4885EGFR 3132/4885DHODH 4474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.